World's Best Scientists 2026 revealed!
British Journal of Haematology
H-index 53

British Journal of Haematology

Ranking & Metrics

Discipline name Position Best Scientists Publications D-Index
Immunology 66 162 222 24
Medicine 216 764 1289 51

Additional Metrics

Number of Best Scientists*: 1266
Documents by Best Scientists*: 1664
Top 100 Ranked Scientists*: 30
SCIMAGO H-index: 215
SCIMAGO SJR: 1.647
Impact Factor: 3.8

Overview

Top Research Topics at British Journal of Haematology?

The aim of the journal is to expand the discussion of research in Internal medicine, Immunology, Pathology, Molecular biology and Cancer research. The research on Internal medicine tackled can also make contributions to studies in the areas of Gastroenterology, Endocrinology, Surgery and Oncology. More specifically, the research on Surgery in the journal is related to Chemotherapy.

Many of the studies tackled connect Immunology with a similar field of study like Stem cell. The journal explores research in Stem cell and the adjacent study of Transplantation. The majority of Pathology studies in British Journal of Haematology are focused on the subject of Lymphoma.

While Molecular biology is the focus of it, it also provided insights into the studies of Genetics, Biochemistry and Gene. The Cancer research study featured in it draws connections with the study of Leukemia.

  • Internal medicine (35.55%)
  • Immunology (28.75%)
  • Pathology (12.21%)

What are the most cited papers published in the journal?

  • Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group. (4974 citations)
  • Proposals for the classification of the myelodysplastic syndromes. (3430 citations)
  • Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group (1682 citations)

Research areas of the most cited articles at British Journal of Haematology:

The most cited papers mainly tackle studies in Internal medicine, Immunology, Surgery, Gastroenterology and Pathology. The journal papers explore issues in Internal medicine which can be linked to other research areas like Endocrinology and Oncology. The most cited articles focus on Immunology but the discussions also offer insight into other areas such as Haematopoiesis and Stem cell.

What topics the last edition of the journal is best known for?

  • Internal medicine
  • Disease
  • Gene

The previous edition focused in particular on these issues:

Internal medicine, Oncology, Cancer research, Coronavirus disease 2019 (COVID-19) and Gastroenterology are among the topics commonly tackled in the journal. In addition to Internal medicine, British Journal of Haematology tackled discussions on In patient. Text mining, Clinical trial, Disease and Chemotherapy are some topics wherein Oncology research discussed in British Journal of Haematology have an impact.

The journal concentrates on Coronavirus disease 2019 (COVID-19) topics that focus on Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and Pandemic. Issues in Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) were discussed, taking into consideration concepts from other disciplines like Virology and 2019-20 coronavirus outbreak. In particular, the Lymphoma works presented emphasize discussions on Diffuse large B-cell lymphoma.

The most cited articles from the last journal are:

  • SARS-CoV-2-induced remission of Hodgkin lymphoma. (27 citations)
  • Von Willebrand factor propeptide in severe coronavirus disease 2019 (COVID-19): evidence of acute and sustained endothelial cell activation. (23 citations)
  • Early mortality benefit with COVID-19 convalescent plasma: a matched control study. (19 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

The top authors publishing in British Journal of Haematology (based on the number of publications) are:

  • David C. Linch (131 papers) published 1 paper at the last edition, 4 less than at the previous edition,
  • Ghulam J. Mufti (118 papers) published 3 papers at the last edition the same number as at the previous edition,
  • David J. Weatherall (102 papers) absent at the last edition,
  • John M. Goldman (79 papers) absent at the last edition,
  • Daniel Catovsky (77 papers) absent at the last edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Only papers with recognized affiliations are considered

The top affiliations publishing in British Journal of Haematology (based on the number of publications) are:

  • Boston Children's Hospital (700 papers) published 43 papers at the last edition, 9 more than at the previous edition,
  • French Institute of Health and Medical Research (514 papers) published 16 papers at the last edition, 1 more than at the previous edition,
  • University of Cambridge (469 papers) published 34 papers at the last edition, 15 more than at the previous edition,
  • University College London (457 papers) published 28 papers at the last edition, 5 more than at the previous edition,
  • Harvard University (433 papers) published 26 papers at the last edition, 6 more than at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 11.63% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 26.44% were posted by at least one author from the top 10 institutions publishing in the journal. Another 7.11% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 18.12% of all publications and 48.32% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

  • Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
  • Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
  • Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
  • Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
  • Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Top Publications

  • Thromboembolic risk and anticoagulant therapy in COVID-19 patients: emerging evidence and call for action.

    Anastasios Kollias;Konstantinos G. Kyriakoulis;Evangelos Dimakakos;Garyphallia Poulakou

    (2020)
    544 Citations
  • Mutation-enhanced international prognostic systems for essential thrombocythaemia and polycythaemia vera.

    Ayalew Tefferi;Paola Guglielmelli;Terra L. Lasho;Giacomo Coltro

    (2020)
    186 Citations
  • Survival study of hospitalised patients with concurrent COVID-19 and haematological malignancies.

    Fernando Martín-Moro;Juan Marquet;Miguel Piris;Berta M Michael

    (2020)
    186 Citations
  • Prophylactic corticosteroid use in patients receiving axicabtagene ciloleucel for large B-cell lymphoma.

    Olalekan O. Oluwole;Krimo Bouabdallah;Javier Muñoz;Sophie De Guibert

    (2021)
    137 Citations
  • Real-world assessment of the clinical impact of symptomatic infection with severe acute respiratory syndrome coronavirus (COVID-19 disease) in patients with multiple myeloma receiving systemic anti-cancer therapy.

    Gordon Cook;A John Ashcroft;Guy Pratt;Rakesh Popat

    (2020)
    124 Citations
  • Azacitidine for patients with Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic syndrome (VEXAS) and myelodysplastic syndrome: data from the French VEXAS registry.

    Thibault Comont;Mael Heiblig;Etienne Rivière;Louis Terriou

    (2021)
    119 Citations
  • Updates on targeted therapies for acute myeloid leukaemia

    Sabine Kayser;Sabine Kayser;Mark J. Levis

    (2021)
    118 Citations
  • Poor outcome and prolonged persistence of SARS-CoV-2 RNA in COVID-19 patients with haematological malignancies; King's College Hospital experience.

    Vallari Shah;Thinzar Ko Ko;Mark Zuckerman;Jennifer Vidler

    (2020)
    117 Citations
  • Practical guidance for the management of adults with immune thrombocytopenia during the COVID-19 pandemic.

    Sue Pavord;Jecko Thachil;Beverley J. Hunt;Mike Murphy

    (2020)
    116 Citations
  • COVID-19 infection in patients with sickle cell disease.

    Faiz A. Hussain;Franklin U. Njoku;Santosh L. Saraf;Robert E. Molokie;Robert E. Molokie

    (2020)
    115 Citations

Related Online Degrees & Career Pathways

For those interested in studying Medicine in the USA, exploring related online degrees can open diverse career opportunities. For example, many professionals choose to specialize by enrolling in psychiatric np programs, which prepare nurses for advanced roles in mental health care—a growing field with a high demand for qualified practitioners.

Nutritional science is another complementary pathway. Students can pursue a holistic nutrition degree online, offering knowledge in diet, wellness, and preventative care. This degree supports careers that blend clinical expertise with lifestyle medicine.

For those interested in the administrative side of healthcare, enrolling in one of the cheapest online mba healthcare management programs is an excellent option. This pathway equips students with leadership skills needed to manage hospitals, clinics, and healthcare organizations effectively.

Lastly, aspiring nurses without a prior degree in nursing might consider online bsn programs for non nurses. These accelerated programs offer a fast track into the nursing profession, crucial for those aiming to enter the medical field quickly and effectively.

Best Scientists Contributing to This Journal